MV Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
15,592
-214
| -1% | -$17.3K | 0.11% | 89 |
|
|
2026
Q1 | $1.37M | Sell |
15,806
-1,680
| -10% | -$161K | 0.13% | 87 |
|
|
2025
Q4 | $1.68M | Buy |
17,486
+288
| +2% | +$28K | 0.16% | 81 |
|
|
2025
Q3 | $1.64M | Sell |
17,198
-331
| -2% | -$30.4K | 0.16% | 84 |
|
|
2025
Q2 | $1.53M | Sell |
17,529
-1,254
| -7% | -$106K | 0.16% | 84 |
|
|
2025
Q1 | $1.69M | Sell |
18,783
-4,625
| -20% | -$414K | 0.18% | 80 |
|
|
2024
Q4 | $1.87M | Sell |
23,408
-11
| -0% | -$952 | 0.2% | 78 |
|
|
2024
Q3 | $2.11M | Sell |
23,419
-1,140
| -5% | -$95.9K | 0.22% | 77 |
|
|
2024
Q2 | $1.93M | Buy |
24,559
+544
| +2% | +$44.6K | 0.22% | 74 |
|
|
2024
Q1 | $2.09M | Buy |
24,015
+15,830
| +193% | +$1.35M | 0.24% | 74 |
|
|
2023
Q4 | $674K | Sell |
8,185
-11,738
| -59% | -$895K | 0.09% | 102 |
|
|
2023
Q3 | $1.56M | Buy |
19,923
+529
| +3% | +$44.3K | 0.21% | 71 |
|
|
2023
Q2 | $1.71M | Buy |
19,394
+3,008
| +18% | +$259K | 0.23% | 63 |
|
|
2023
Q1 | $1.32M | Buy |
16,386
+354
| +2% | +$28.9K | 0.19% | 71 |
|
|
2022
Q4 | $1.25M | Buy |
16,032
+272
| +2% | +$22K | 0.19% | 68 |
|
|
2022
Q3 | $1.27M | Buy |
15,760
+3,284
| +26% | +$295K | 0.22% | 64 |
|
|
2022
Q2 | $1.12M | Sell |
12,476
-649
| -5% | -$65.8K | 0.19% | 72 |
|
|
2022
Q1 | $1.46M | Buy |
13,125
+789
| +6% | +$83.4K | 0.22% | 73 |
|
|
2021
Q4 | $1.28M | Buy |
12,336
+7
| +0.1% | +$811 | 0.19% | 72 |
|
|
2021
Q3 | $1.54M | Buy |
12,329
+837
| +7% | +$108K | 0.26% | 68 |
|
|
2021
Q2 | $1.43M | Buy |
11,492
+640
| +6% | +$80.4K | 0.24% | 72 |
|
|
2021
Q1 | $1.28M | Buy |
10,852
+1,691
| +18% | +$198K | 0.23% | 69 |
|
|
2020
Q4 | $1.07M | Buy |
9,161
+1,076
| +13% | +$118K | 0.2% | 65 |
|
|
2020
Q3 | $840K | Buy |
8,085
+2,082
| +35% | +$209K | 0.17% | 62 |
|
|
2020
Q2 | $550K | Buy |
6,003
+1,487
| +33% | +$143K | 0.13% | 70 |
|
|
2020
Q1 | $407K | Buy |
4,516
+567
| +14% | +$60.3K | 0.11% | 69 |
|
|
2019
Q4 | $448K | Buy |
3,949
+399
| +11% | +$43.8K | 0.1% | 81 |
|
|
2019
Q3 | $386K | Buy |
3,550
+229
| +7% | +$23.9K | 0.09% | 81 |
|
|
2019
Q2 | $323K | Buy |
3,321
+457
| +16% | +$41.7K | 0.07% | 85 |
|
|
2019
Q1 | $261K | Buy |
2,864
+284
| +11% | +$25.4K | 0.06% | 92 |
|
|
2018
Q4 | $235K | Buy |
2,580
+230
| +10% | +$21.5K | 0.07% | 87 |
|
|
2018
Q3 | $231K | Sell |
2,350
-36
| -2% | -$3.33K | 0.06% | 91 |
|
|
2018
Q2 | $204K | Buy |
2,386
+7
| +0.3% | +$585 | 0.05% | 94 |
|
|
2018
Q1 | $191K | Sell |
2,379
-63
| -3% | -$5.2K | 0.05% | 97 |
|
|
2017
Q4 | $197K | Sell |
2,442
-20
| -0.8% | -$1.6K | 0.05% | 100 |
|
|
2017
Q3 | $191K | Sell |
2,462
-268
| -10% | -$22.3K | 0.05% | 95 |
|
|
2017
Q2 | $242K | Buy |
2,730
+79
| +3% | +$6.66K | 0.07% | 82 |
|
|
2017
Q1 | $214K | Sell |
2,651
-3
| -0.1% | -$234 | 0.07% | 89 |
|
|
2016
Q4 | $189K | Sell |
2,654
-278
| -9% | -$21.8K | 0.07% | 92 |
|
|
2016
Q3 | $253K | Sell |
2,932
-452
| -13% | -$39.4K | 0.09% | 71 |
|
|
2016
Q2 | $294K | Buy |
3,384
+180
| +6% | +$14.6K | 0.11% | 72 |
|
|
2016
Q1 | $240K | Buy |
3,204
+716
| +29% | +$53.9K | 0.1% | 77 |
|
|
2015
Q4 | $191K | Buy |
2,488
+816
| +49% | +$61.4K | 0.08% | 95 |
|
|
2015
Q3 | $112K | Buy |
1,672
+495
| +42% | +$36.5K | 0.05% | 109 |
|
|
2015
Q2 | $87K | Buy |
1,177
+251
| +27% | +$19.2K | 0.04% | 134 |
|
|
2015
Q1 | $72K | Hold |
926
| – | – | 0.03% | 143 |
|
|
2014
Q4 | $67K | Buy |
+926
| New | +$64.3K | 0.03% | 144 |
|
Other funds holding MDT
FWIA
GAM
SRIM
DC
MV Capital Management's MDT Position: Q2 2026 in Review
MV Capital Management reduced its Medtronic (MDT) stake by 1.4% in Q2 2026, selling an estimated $17.3K and leaving 15,592 shares worth $1.22M. The position accounts for 0.11% of the portfolio, ranked #89.
MV Capital Management first reported a position in MDT in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.11M in Q3 2024. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- MV Capital Management held 15,592 shares of Medtronic worth $1.22M as of Q2 2026.
- MV Capital Management sold 214 Medtronic shares in Q2 2026, an estimated $17.3K.
- Medtronic made up 0.11% of MV Capital Management's portfolio in Q2 2026, its #89 holding.
- MV Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 47 quarters since.
- MV Capital Management's Medtronic position peaked at $2.11M in Q3 2024.
- 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.